Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
By T. Guo, YongZhen Fan, Ming Chen, Xiaoyan Wu, Lin Zhang, T. He, Hairong Wang, J. Wan, Xinghuan Wang, Zhibing Lu. JAMA cardiology, 2020
3,798 citations recorded by the source corpus.
This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
Subfields: Cardiology and Cardiovascular Medicine, Infectious Diseases, Oncology
View Paper: https://www.semanticscholar.org/paper/4d079ccd7d13cc82bbdddb2b9b2212ed0d49c30f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. (2020, neutral): “Coronary artery disease 16 (52) 479 (25)”
- Cardiovascular complications in COVID-19 (2020, neutral): “Prior viral illnesses, including Middle East respiratory syndrome coronavirus (MERS-CoV), have been associated with myocardial injury and myocarditis with troponin elevation, thought to be due to increased cardiac physiologic stress, hypoxia, or direct myocardial injury [4, [24] [25] [26] [27] [28] ”
- Predictors of COVID-19 severity: A literature review (2020, background): “dehydrogenase (LDH), have been linked to greater disease severity.(6,9,10,20,75,81,103) Recent data suggest that LDH may be related to respiratory function and be an important predictor of respiratory failure in COVID-19 patients.”
- Multisystem Inflammatory Syndrome in U.S. Children and Adolescents (2020, neutral): “(%)** 21/62 (34) 15/55 (27) 9/36 (25) 45/153 (29)”
- Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment (2020, background): “tions, there are solid reasons to be tremendously concerned about the consequences of this viral infection [5].”